Evidence map›Paper›PMID 39117678›Full record

Articlenpj aging2024

Precious2GPT: the combination of multiomics pretrained transformer and conditional diffusion for artificial multi-omics multi-species multi-tissue sample generation.

Denis Sidorenko, Stefan Pushkov, Akhmed Sakip, Geoffrey Ho Duen Leung, Sarah Wing Yan Lok, Anatoly Urban, Diana Zagirova, Alexander Veviorskiy, Nina Tihonova, Aleksandr Kalashnikov and 6 more

Abstract read
In one paragraph

Article in npj aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Target identification and assessment in the era of AI.Nature reviews. Drug discovery · 2026
    Review
  2. AI for scientific discovery is a social problem.Patterns (New York, N.Y.) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Denis SidorenkoInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.ORCID http://orcid.org/0009-0004-0571-5192
Stefan PushkovInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Akhmed SakipInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Geoffrey Ho Duen LeungInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Sarah Wing Yan LokInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Anatoly UrbanInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Diana ZagirovaInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Alexander VeviorskiyInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, Abu Dhabi, UAE.
Nina TihonovaInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, Abu Dhabi, UAE.
Aleksandr KalashnikovInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, Abu Dhabi, UAE.
Ekaterina KozlovaInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Vladimir NaumovInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.
Frank W PunInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China.ORCID http://orcid.org/0000-0001-8801-6645
Alex AliperInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, Abu Dhabi, UAE.
Feng RenInsilico Medicine Shanghai Ltd., Suite 902, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong, Shanghai, 201203, China.
Alex ZhavoronkovInsilico Medicine Hong Kong Ltd., Unit 310, 3/F, Building 8W Hong Kong Science and Technology Park, Hong Kong SAR, China. alex@insilico.com.ORCID http://orcid.org/0000-0001-7067-8966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic data generation in omics mimics real-world biological data, providing alternatives for training and evaluation of genomic analysis tools, controlling differential expression, and exploring data architecture. We previously developed Precious1GPT, a multimodal transformer trained on transcriptomic and methylation data, along with metadata, for predicting biological age and identifying dual-purpose therapeutic targets potentially implicated in aging and age-associated diseases. In this study, we introduce Precious2GPT, a multimodal architecture that integrates Conditional Diffusion (CDiffusion) and decoder-only Multi-omics Pretrained Transformer (MoPT) models trained on gene expression and DNA methylation data. Precious2GPT excels in synthetic data generation, outperforming Conditional Generative Adversarial Networks (CGANs), CDiffusion, and MoPT. We demonstrate that Precious2GPT is capable of generating representative synthetic data that captures tissue- and age-specific information from real transcriptomics and methylomics data. Notably, Precious2GPT surpasses other models in age prediction accuracy using the generated data, and it can generate data beyond 120 years of age. Furthermore, we showcase the potential of using this model in identifying gene signatures and potential therapeutic targets in a colorectal cancer case study.

Identifiers

PMID39117678
PMCPMC11310469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.